Schneyer Mark C. bought ACAD
March 24, 2026 · Form 4 insider transaction
Schneyer Mark C. bought 8,138 shares of ACADIA Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,138
Price
N/A
Total value
N/A
InsiderSchneyer Mark C.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 24, 2026
Filing dateMarch 26, 2026
Shares owned after61,476
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.